Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 440-520-9 | CAS number: 204583-39-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Currently no LLNA study is available for assessment. The Guinea Pig Maximization Test (GPMT) has been carried out as an animal test to predict human sensitization for over a decade and is recommended by international test guidelines such as OECD.
Test material
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI; SPF-quality guinea pigs (synonym: Himalayan spotted)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS- Source: RCC Ltd, Biotechnology & Animal Breeding Division, Fuellinsdorf / Switzerland- Age at study initiation: 3 - 6 weeks- Weight at study initiation: 379 - 426 g- Housing: Individually in Makrolon type-4 cages with standard softwood bedding ("Lignocel", Schill AG, Muttenz)- Diet (e.g. ad libitum): Pelleted standard Provimi Kliba 3418, batch no. 93/01, guinea pig breeding / maintenance diet, containing Vitamin C (Provimi Kliba AG, Kaiseraugst), ad libitum.- Water (e.g. ad libitum): Community tap water from Fiillinsdorf, ad libitum- Acclimation period: One weekENVIRONMENTAL CONDITIONS- Temperature (°C): 20 ± 3- Humidity (%): 30-70- Air changes (per hr): 10-15- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark.
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 300
- Concentration / amount:
- intradermal induction: 10% test itemepidermal induction: 25% test item
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Remarks:
- PEG 300
- Concentration / amount:
- 0.2 mL of 1% test item
- Day(s)/duration:
- 24 hours, two weeks after epidermal induction
- No. of animals per dose:
- 15 males for main study5 males for pretests
- Details on study design:
- RANGE FINDING TESTS: To determine the different concentrations one intradermal and two epidermal pretests were performed. Intradermal injections (0.1 ml/site) were made into the clipped flank of the same guinea pig at concentrations of 10 %, 5 % and 3% of the test item in PEG 300. The three concentrations were determined during non-GLP formulation trials performed before the study initiation date. The concentration of 10 % was considered to be the highest technically applicable concentration which could be injected into the intra-cellular space in spite of the high viscosity of the application dilution and the obstacle caused by the tissues. For intradermal injections4 patches of filter paper (3x3 cm) were saturated with the test item at 25 % (technically the highest possible concentration to be applied sufficiently), 15 %, 10 % and 5 % in PEG 300 and applied to the clipped and shaved flanks. The amount of test item preparation applied was approximately 0.2 g for the test item at 25 % and a volume of approximately 0.2 ml was applied for the remaining test item concentrations. The patches were covered by a strip of aluminum foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test item. The dressings were removed after an exposure period of 24 hours.Twenty-one hours after removal of the dressing the application site was depilated with an approved depilatory cream (VEET Cream, Reckitt & Colman AG, Allschwil) in order to visualize any resulting erythema. The depilatory cream was placed on the patch sites and surrounding areas, and left on for 3-5 minutes. It was then thoroughly washed off with a stream of warm, running water. Thereafter, the animals were dried with a disposable towel, and returned to their cages. The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema according to the method of Magnusson and Kligman.MAIN STUDYA. INDUCTION EXPOSUREIntradermal inductionTest Group: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.2) The test item, at 10 % in PEG 300.3) The test item at 10 % in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.Control Group: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.2) PEG 3003) 1:1 (w/w) mixture of PEG 300 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.Epidermal induction on test day 8:- Time point of exposure: One week after the intradermal induction- Exposure period: 48 hours- Site: scapular area- Exposure area: 2 x 4 cm patch of filter paper was saturated with the test item and placed over the injection sites of the test animals- Amount applied: approximately 0.3 g- Concentrations: 25 % test item in PEG 300B. CHALLENGE EXPOSURE- Time point of exposure: test and control guinea pigs were challenged two weeks after the epidermal induction- Exposure period: 24 hours- Site: on the left and right flank of each guinea pig just prior to the application; test item was applied to the left flank, vehicle only (PEG 300) was applied to the right flank- Exposure area: 3x3 cm; two patches of filter paper were saturated with the test item at the highest tested non-irritating concentration- Concentrations: 1% test item in vehicle and the vehicle only (PEG 300) using the same method as for the epidermal application.- Amount applied: approximately 0.2 ml- Evaluation (hr after challenge): 24 and 48 hours after removal of the bandage for erythema and oedema according to the method of Magnusson and Kligman.
- Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- vehicle alone
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No findings noted.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- vehicle alone
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No findings noted.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1% test item in PEG
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No findings noted. But animal no. 52 died.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% test item in PEG
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No findings observed. But animal no. 62 died.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies